CN Patent
CN102256971B — 作为杀虫剂的异噁唑啉衍生物及其用途
Assigned to Swiss Iran Animal Health Care Co Ltd · Expires 2014-09-17 · 12y expired
What this patent protects
本发明涉及式(I)的新的异噁唑啉化合物,其中各变量具有权利要求书中指明的含义;以游离形式和盐形式存在;并任选其对映体和几何异构体。式(I)化合物用于温血动物中和表面的寄生虫、特别是体外寄生虫的控制。
USPTO Abstract
本发明涉及式(I)的新的异噁唑啉化合物,其中各变量具有权利要求书中指明的含义;以游离形式和盐形式存在;并任选其对映体和几何异构体。式(I)化合物用于温血动物中和表面的寄生虫、特别是体外寄生虫的控制。
Drugs covered by this patent
- Xdemvy (LOTILANER) · Tarsus
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.